This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Breast Cancer Treatment by Stina Mui Singel
Introduction
Stina Mui Singel is a prominent inventor based in Menlo Park, California, known for her groundbreaking work in the field of oncology. With expertise in developing innovative treatments, she has contributed significantly to advancements in breast cancer therapies.
Latest Patents
Stina holds a patent for a novel treatment of breast cancer utilizing combination therapies. Her patented approach involves the use of an AKT inhibitor, a taxane, and a PD-L1 inhibitor. This innovative therapy is specifically designed for the treatment of Metastatic Triple-Negative Breast Cancer (MTNBC) and locally advanced Triple-Negative Breast Cancer (TNBC).
Career Highlights
Stina is affiliated with Genentech, Inc., a leading biotechnology company dedicated to developing innovative medicines. Her work focuses on refining therapeutic strategies that can enhance treatment outcomes for patients suffering from breast cancer.
Collaborations
Throughout her career, Stina has collaborated with other notable professionals in the field, including Nimali Piyushika Withana and Aruna Mani. These partnerships have been instrumental in fostering innovation and advancing research within the domain of cancer treatment.
Conclusion
Stina Mui Singel's contributions to breast cancer treatment reflect her dedication to improving patient care through innovative therapies. Her patent and ongoing work at Genentech, Inc. signify a promising future for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile